Objective
Corneal blindness is the 3rd leading cause of blindness globally, affecting >11.7mi people. Although the cornea is the most transplanted tissue, only 1-in-70 patients in need receive a cornea due to a severe shortage of donor tissue.
3D bioprinting offers an attractive solution. However, existing technology cannot mimic the complexity of cornea tissue, which is necessary to reproduce its optomechanical & biological functionality.
The KeratOPrinter project thus, proposes a highly ambitious approach to develop a 4D bioprinting suite that can deliver a fully functional, biocompatible, full-thickness native-like human cornea. The consortium combines world-class partners to provide:
a) An innovative & scalable cell source with high cell viability & native-like functionality in vivo for the different cell types in the cornea; b) Several multi-material bioink formulations which can reproduce the native-environment heterogeneity & extracellular matrix to deliver the optical, mechanical & biological functionality; c) Single-cell bioprinting resolution with µm accuracy & in-process monitoring for clinical-level quality control at viable printing speeds; d) Clinical handling technology for transportation, logistics & surgical implementation, supported by complementary implementation of multiple bioprinting technologies; e) GMP-compliant cell manufacturing and bioprinting technologies supported by in vivo & GLP studies for fast translation to the clinical environment; f) Early regulatory engagement augmented by a thorough regulatory and ethical analysis culminating in a comprehensive regulatory pathway to support future commercialisation and g) A dedicated community of researchers, clinicians, healthcare providers, regulatory and standardisation bodies, patient groups, technology developers, & industry to translate project results into targeted outcomes & long-term impacts.
Ultimately, KeratOPrinter aims to enable millions of people to receive vision-saving therapy by 2035.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.2.1 - Health
MAIN PROGRAMME
See all projects funded under this programme -
HORIZON.2.1.5 - Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-RIA - HORIZON Research and Innovation Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-HLTH-2024-TOOL-11
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
33100 TAMPERE
Finland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.